OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
December 12, 2022
The R&D analytical solutions will consist of analytical lab services that use USP’s in-house scientific expertise and state-of-the-art facilities at the USP Advanced Manufacturing Technology Lab in Richmond and the USP headquarters facility in Rockville, Md.
December 08, 2022
FDA struggles to track shortages caused by a rise in demand.
The most safe and effective therapies demand the highest data quality.
December 07, 2022
Ferring Pharmaceuticals’ Rebyota was approved for the prevention of recurrence of Clostridioides difficile infection.
The partnership will see the pharma giants partner with researchers from A*STAR and various Singapore universities.
In this episode of the Drug Solutions Podcast, Chris Spivey interviews executives at Shabas Solutions LLC, who ran the overseas QMM pilot project.
Advances in contamination control are being to mitigate the presence of pollutants in drug products.
One can improve method precision and productivity by replacing one step in sample preparation with an automated approach.
Advancing digital transformation can significantly reduce R&D costs and shorten drug discovery timelines.
Pharmaceutical Technology editors interview an automation expert from Automata on the benefits of automating entire workflows in analytics versus automating only specific pieces of equipment or only certain processes.